Mechanistic effect of NMSO3 on replication of human immunodeficiency virus

Antiviral Chemistry and Chemotherapy

Volumn 14, Issue 4, 2003, Pages 171-176

  Nakamura, Mariko ^a   Terada, Masaki ^b   Kamada, Minori ^a   Yokono, Akira ^a   Nakamori, Shogo ^a   Ohno, Tsuneya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nissin Central Research Institute   (Japan)

Author keywords

Antiviral; CD4; HIV 1; Sialic acid

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EPITOPE; GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG; [2,2 BIS(DOCOSYLOXYMETHYL)PROPYL 5 ACETOAMIDO 3,5 DIDEOXY 4,7,8,9 TETRA O (SODIUM OXYSULFONYL) DEXTRO GLYCEROL ALPHA DEXTRO GALACTO 2 NONULOPYRANOSID]ONATE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INHIBITION;

EID: 0142011523     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020301400401     Document Type: Article

References (25)

1. Apostolakos MJ, Schuermann WH, Frampton MW, Utell MJ & Willey JC (1993) Measurement of gene expression by multiple competitive polymerase chain reactions. Analytical Biochemistry 213:277-284.
2. Arthos J, Deen KC, Shatzman A, Truneh A, Rosenberg M & Sweet RW (1990) The genetic analysis of the HIV envelope binding domain on CD4. Annals of the New York Academy of Science 616:116-124.
3. Benkirane M, Corboeau P, Housset V & Devaux C (1993) An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-1 infected T cells. EMBO Journal 12:4909-4921.
4. Benkirane M, Schmid-Antomarchi H, Littman DR, Hirn M, Rossi B & Devaux C (1995) The cytoplasmic tail of the CD4 molecule is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind the CDR3-like region of the D1 domain of CD4. Journal of Virology 69:6904-6910.
5. Briant L, Signoret N, Gaubin M, Robert-Hebmann V, Zhang X, Murali R, Greene MI, Piatier-Tonneau D & Devaux C (1997) Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4. Journal of Biological Chemistry 272:19441-19450.
6. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer S-M, Hirsch M-S, Jacobsen D-M, Katzenstein D-A, Montaner J-S, Richman D-D, Saag M-S, Schechter M, Schooley R-T, Thompson M-A, Vella S, Yeni P-G & Volberding P-A (2000) Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association 283:381-390.
7. Clayton LK, Sieh M, Pious DA & Reinherz EL (1989) Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339:548-551.
8. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe Vj, Friedman HM, Merigan TC, Reichman RC, Hooper C & Corey L (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. New England Journal of Medicine 334:1011-1017.
9. Davis AJ, Peng L & Burrell CJ (1997) Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1. Journal of General Virology 78:1897-1906.
10. Debul M, Chun TW, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Callahan CW, Justment JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ & Fauci AS (2001) Short-cycle structures intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. Proceedings of the National Academy of Science, USA 98:15161-15166.
11. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S & Vance PJ (1996) CD4-dependent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
12. Fujita S, Numata M, Suzuki K, Sugimoto M & Terada M (1997). Novel compounds having anti-viral activity. Japanese patent application, PCT/JP97/01654, WO97/43296.
13. Hoffman AD, Banapour B & Levy JA (1985) Characterization of the AIDS associated retroviruses reverse transcripts and optical conditions for its detection in vitro. Virology 147:326-335.
14. Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, Siliciano RF, Dorfman T, Walker B, Sodroski J & Reinherz EL (1988) A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature 331:78-81.
15. Ito M, Baba M, Sato A, Pauwels R, D Clercq E & Shigeta S (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immuno-deficiency virus (HIV) in vitro. Antiviral Research 7:361-367.
16. Kimura K, Mori S, Tomita K, Ohno K, Takahashi K, Shigeta S & Terada M (2000) Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral Research 47:41-51.
17. Koup RA (2001) A new latent HIV reservoir. Nature Medicine 7:404-405.
18. Mastromarino P., Petruzziollo R, Macchia S, Rieti S, Nicoletti R & Orsi N (1997) Antiviral activity of natural and semisynthetic polysaccharides on the early steps of rubella virus infection. Journal of Antimicrohial Chemotherapy 39:339-345.
19. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW & Broder S (1985) 3′-Azido-3′ -deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proceedings of the National Academy of Science, USA 82:7096-7100.
20. Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J, Zhao L, Olson W, Kwong PD & Sattentau QI (2000) Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. Journal of Virology 74:1948-1960.
21. Perelson AS, Newman AU, Markowits M, Leonard JM & Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
22. Peterson A & Seed B (1988) Genetic analysis of monoclonal antibody and HIV binding sites of the human lymphocyte antigen CD4. Cell 54:65-72.
23. Popovic M, Sarngadharan MG, Read E & Gallo RC (1984) Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-550.
24. Schmid-Antomarchi H, Benkirane M, Breittmaver V, Husson H, Ticchioni M, Devaux C & Rossi B (1996) HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. European Journal of Immunology 26:717-720.
25. Twentyman PR & Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemotherapy. British Journal of Cancer 56:279-285.